Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.


Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence


Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
News18 » India
1-min read

As China Battles Coronavirus, Indian Pharma Industry Sounds Alarm over Stock of APIs

India currently imports Rs 17,000 crore worth of active pharmaceutical ingredient from China, as it continues to remain badly affected by the Novel Coronavirus.


Updated:February 18, 2020, 7:29 PM IST
facebookTwitter Pocket whatsapp
As China Battles Coronavirus, Indian Pharma Industry Sounds Alarm over Stock of APIs
Representative Image

Hyderabad: Describing the situation in termsof raw material import from China as "grim," India Pharmaceutical Alliance (IPA) said the Indian pharmaceutical industry has enough stock of active pharmaceutical ingredient (APIs) for just two to three months.

Speaking on the sidelines of BioAsia 2020, IPA Secretary General Sudarshan Jain said they were in touch with the Centre, seeking faster environmental clearances for some of the API manufacturing units so that dependence on China was reduced.

According to Jain, India imports Rs 17,000 crore worth of APIs from the Novel Coronavirus-hit nation.

"It is a very critical and serious situation. No one has got the full predictability of what is happening. We have inventories for two to three months," Jain said.

"What we are trying to do is work with the government to see the environmental clearances can be given faster wherever there are issues, so that they (the APIs which are being imported from China) can be manufactured in India and we can have alternate source of supplies," he said.

Jain said as such China has extended Lunar holidays in that country and the situation may ease from March first week.

"If we start having the supplies from first week of March (from China), we should be able to come out of the problem. However, it is very difficult to predict whether situation improves. We are monitoring the situation on a daily basis," he added.

Replying to a query, he said the Indian Pharma industry may also consider some of the European destinations for API supplies.

Support the daily wage earners who have been hit the hardest by the COVID-19 crisis. Click here to contribute to the cause. #IndiaGives

The daily News18 Coronavirus COVID-19 newsletter - Get your copy here.

Subscribe to News18 Daybreak. Follow us on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube

| Edited by: ---
Read full article

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results


  • Active Cases


  • Total Confirmed


  • Cured/Discharged


  • Total DEATHS


Data Source: Ministry of Health and Family Welfare, India
Updated: April 04 (09:00 AM)
Hospitals & Testing centres


  • Active Cases


  • Total Confirmed


  • Cured/Discharged


  • Total DEATHS


Data Source: Johns Hopkins University, U.S. (www.jhu.edu)
Hospitals & Testing centres